Publikationen 2018

Kravic B, Harbauer AB, Romanello V, Simeone L, Vögtle FN, Kaiser T, Straubinger M, Huraskin D, Böttcher M, Cerqua C, Martin ED, Poveda-Huertes D, Buttgereit A, Rabalski AJ, Heuss D, Rudolf R, Friedrich O, Litchfield D, Marber M, Salviati L, Mougiakakos D, Neuhuber W, Sandri M, Meisinger C, Hashemolhosseini S:(2018)In mammalian skeletal muscle, phosphorylation of TOMM22 by protein kinase CSNK2/CK2 controls mitophagy.Autophagy. 2018;14(2): 311-335
Springer J, White PL, Kessel J, Wieters I, Teschner D, Korczynski D, Liebregts T, Cornely OA, Schwartz S, Elgeti T, Meintker L, Krause SW, Posso RB, Heinz WJ, Fuhrmann S, Vehreschild JJ, Einsele H, Rickerts V, Loeffler J:(2018)A Comparison of Aspergillus and Mucorales PCR Testing of Different Bronchoalveolar Lavage Fluid Fractions from Patients with Suspected Invasive Pulmonary Fungal Disease.J Clin Microbiol. 2018;56(2):
McDonald MP, Gemeinhardt A, König K, Piliarik M, Schaffer S, Völkl S, Aigner M, Mackensen A, Sandoghdar V:(2018)Visualizing Single-Cell Secretion Dynamics with Single-Protein Sensitivity.Nano Lett. 2018;18(1): 513-519
Mellinghoff SC, Panse J, Alakel N, Behre G, Buchheidt D, Christopeit M, Hasenkamp J, Kiehl M, Koldehoff M, Krause SW, Lehners N, von Lilienfeld-Toal M, Löhnert AY, Maschmeyer G, Teschner D, Ullmann AJ, Penack O, Ruhnke M, Mayer K, Ostermann H, Wolf HH, Cornely OA:(2018)Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).Ann Hematol. 2018;97(2): 197-207
Lucas S, Omata Y, Hofmann J, Böttcher M, Iljazovic A, Sarter K, Albrecht O, Schulz O, Krishnacoumar B, Krönke G, Herrmann M, Mougiakakos D, Strowig T, Schett G, Zaiss MM:(2018)Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss.Nat Commun. 2018;9(1): 55
Ullrich E, Abendroth B, Rothamer J, Huber C, Büttner-Herold M, Buchele V, Vogler T, Longerich T, Zundler S, Völkl S, Beilhack A, Rose-John S, Wirtz S, Weber GF, Ghimire S, Kreutz M, Holler E, Mackensen A, Neurath MF, Hildner K:(2018)BATF-dependent IL-7RhiGM-CSF+ T cells control intestinal graft-versus-host disease.J Clin Invest. 2018;128(3): 916-930
Grafe C, Semrau S, Hein A, Beckmann MW, Mackensen A, Dörje F, Fromm MF:(2018)Dose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safety.Naunyn Schmiedebergs Arch Pharmacol. 2018;391(2): 219-229
Schwab A, Siddiqui A, Vazakidou ME, Napoli F, Böttcher M, Menchicchi B, Raza U, Saatci Ö, Krebs AM, Ferrazzi F, Rapa I, Dettmer-Wilde K, Waldner MJ, Ekici AB, Rasheed SAK, Mougiakakos D, Oefner PJ, ?ahin Ö, Volante M, Greten FR, Brabletz T, Ceppi P:(2018)Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells.Cancer Res. 2018;78(7): 1604-1618
Mathew NR, Baumgartner F, Braun L, O'Sullivan D, Thomas S, Waterhouse M, Müller TA, Hanke K, Taromi S, Apostolova P, Illert AL, Melchinger W, Duquesne S, Schmitt-Graeff A, Osswald L, Yan KL, Weber A, Tugues S, Spath S, Pfeifer D, Follo M, Claus R, Lübbert M, Rummelt C, Bertz H, Wäsch R, Haag J, Schmidts A, Schultheiss M, Bettinger D, Thimme R, Ullrich E, Tanriver Y, Vuong GL, Arnold R, Hemmati P, Wolf D, Ditschkowski M, Jilg C, Wilhelm K, Leiber C, Gerull S, Halter J, Lengerke C, Pabst T, Schroeder T, Kobbe G, Rösler W, Doostkam S, Meckel S, Stabla K, Metzelder SK, Halbach S, Brummer T, Hu Z, Dengjel J, Hackanson B, Schmid C, Holtick U, Scheid C, Spyridonidis A, Stölzel F, Ordemann R, Müller LP, Sicre-de-Fontbrune F, Ihorst G, Kuball J, Ehlert JE, Feger D, Wagner EM, Cahn JY, Schnell J, Kuchenbauer F, Bunjes D, Chakraverty R, Richardson S, Gill S, Kröger N, Ayuk F, Vago L, Ciceri F, Müller AM, Kondo T, Teshima T, Klaeger S, Kuster B, Kim DDH, Weisdorf D, van der Velden W, Dörfel D, Bethge W, Hilgendorf I, Hochhaus A, Andrieux G, Börries M, Busch H, Magenau J, Reddy P, Labopin M, Antin JH, Henden AS, Hill GR, Kennedy GA, Bar M, Sarma A, McLornan D, Mufti G, Oran B, Rezvani K, Sha O, Negrin RS, Nagler A, Prinz M, Burchert A, Neubauer A, Beelen D, Mackensen A, von Bubnoff N, Herr W, Becher B, Socié G, Caligiuri MA, Ruggiero E, Bonini C, Häcker G, Duyster J, Finke J, Pearce E, Blazar BR, Zeiser R:(2018)Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.Nat Med. 2018;24(3): 282-291
Müller F, Cunningham T, Stookey S, Tai CH, Burkett S, Jailwala P, Stetler Stevenson M, Cam MC, Wayne AS, Pastan I:(2018)5-Azacytidine prevents relapse and produces long-term complete remissions in leukemia xenografts treated with Moxetumomab pasudotox.Proc Natl Acad Sci U S A. 2018;115(8): E1867-E1875
Arnold ML, Bach C, Heinemann FM, Dick A, Spriewald BM:(2018)DONOR SPECIFIC ANTI-HLA IGA ANTIBODIES AND GRAFT SURVIVAL AFTER KIDNEY TRANSPLANTATIONHLA. 2018;91(5): 358-358
Loschinski R, Böttcher M, Stoll A, Bruns H, Mackensen A, Mougiakakos D:(2018)IL-21 modulates memory and exhaustion phenotype of T-cells in a fatty acid oxidation-dependent manner.Oncotarget. 2018;9(17): 13125-13138
Busch L, Mougiakakos D, Büttner-Herold M, Müller MJ, Volmer DA, Bach C, Fabri M, Bittenbring JT, Neumann F, Boxhammer R, Nolting J, Bisht S, Böttcher M, Jitschin S, Hoffmann MH, Balzer H, Beier F, Gezer D, Dudziak D, Gelse K, Hennig FF, Pallasch CP, Spriewald B, Mackensen A, Bruns H:(2018)Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway.Leukemia. 2018;32(11): 2445-2458
Gary R, Aigner M, Moi S, Schaffer S, Gottmann A, Maas S, Zimmermann R, Zingsem J, Strobel J, Mackensen A, Mautner J, Moosmann A, Gerbitz A:(2018)Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts.J Transl Med. 2018;16(1):
Arnold ML, Bach C, Heinemann FM, Horn PA, Ziemann M, Lachmann N, Mühlbacher A, Dick A, Ender A, Thammanichanond D, Schaub S, Hönger G, Fischer GF, Mytilineos J, Hallensleben M, Hitzler WE, Seidl C, Spriewald BM:(2018)Anti-HLA alloantibodies of the IgA isotype in re-transplant candidates part II: Correlation with graft survival.Int J Immunogenet. 2018;45(3): 95-101
Arnold ML, Kainz A, Hidalgo LG, Eskandary F, Kozakowski N, Wahrmann M, Haslacher H, Oberbauer R, Heilos A, Spriewald BM, Halloran PF, Böhmig GA:(2018)Functional Fc gamma receptor gene polymorphisms and donor-specific antibody-triggered microcirculation inflammation.Am J Transplant. 2018;18(9): 2261-2273
Zecher D, Bach C, Preiss A, Staudner C, Utpatel K, Evert M, Jung B, Bergler T, Böger CA, Spriewald BM, Banas B:(2018)Analysis of Luminex-based Algorithms to Define Unacceptable HLA Antibodies in CDC-crossmatch Negative Kidney Transplant Recipients.Transplantation. 2018;102(6): 969-977
Major-Monfried H, Renteria AS, Pawarode A, Reddy P, Ayuk F, Holler E, Efebera YA, Hogan WJ, Wölfl M, Qayed M, Hexner EO, Wudhikarn K, Ordemann R, Young R, Shah J, Hartwell MJ, Chaudhry M, Aziz M, Etra A, Yanik GA, Kröger N, Weber D, Chen YB, Nakamura R, Rösler W, Kitko CL, Harris AC, Pulsipher M, Reshef R, Kowalyk S, Morales G, Torres I, Özbek U, Ferrara JLM, Levine JE:(2018)MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD.Blood. 2018;131(25): 2846-2855
Böttcher M, Renner K, Berger R, Mentz K, Thomas S, Cardenas-Conejo ZE, Dettmer K, Oefner PJ, Mackensen A, Kreutz M, Mougiakakos D:(2018)D-2-hydroxyglutarate interferes with HIF-1α stability skewing T-cell metabolism towards oxidative phosphorylation and impairing Th17 polarization.Oncoimmunology. 2018;7(7):
Buchele V, Abendroth B, Büttner-Herold M, Vogler T, Rothamer J, Ghimire S, Ullrich E, Holler E, Neurath MF, Hildner K:(2018)Targeting Inflammatory T Helper Cells via Retinoic Acid-Related Orphan Receptor Gamma t Is Ineffective to Prevent Allo-Response-Driven Colitis.Front Immunol. 2018;9():
Schröder SD, Krause SW, Erfurt-Berge C:(2018)Genital ulcers as diagnostic clue for acute myeloid leukaemia.Int Wound J. 2018;15(5): 845-848
Müller F, Cunningham T, Beers R, Bera TK, Wayne AS, Pastan I:(2018)Domain II of Pseudomonas Exotoxin Is Critical for Efficacy of Bolus Doses in a Xenograft Model of Acute Lymphoblastic Leukemia.Toxins (Basel). 2018;10(5):
Spriewald BM, Bach C, Zingsem J, Strobel J, Winkler J, Mackensen A, Roesler W:(2018)Depletion of donor-specific anti-HLA A2 alloantibodies in a hematopoietic cell transplant recipient using directed mismatched platelet transfusions.Bone Marrow Transplant. 2018;53(6): 791-794
Gebauer J, Rieken S, Schuster S, Hahn B, Gebauer N, Meidenbauer N, Brabant G, Metzler M, Langer T:(2018)Multidisciplinary Late Effects Clinics for Childhood Cancer Survivors in Germany - a Two-Center Study.Oncology Research and Treatment. 2018;41(7-8): 430-436
Vielreicher M, Kralisch D, Völkl S, Sternal F, Arkudas A, Friedrich O:(2018)Bacterial nanocellulose stimulates mesenchymal stem cell expansion and formation of stable collagen-I networks as a novel biomaterial in tissue engineering.Sci Rep. 2018;8(1):
Zirlik S, Neurath MF, Meidenbauer N, Vieth M, Fuchs FS:(2018)Identification of Bronchoalveolar Lavage Components Applying Confocal Laser Endomicroscopy.Med Sci Monit. 2018;24(): 4198-4203
Kremer AN, Zonneveld MI, Kremer AE, van der Meijden ED, Falkenburg JHF, Wauben MHM, Nolte-'t Hoen ENM, Griffioen M:(2018)Natural T-cell ligands that are created by genetic variants can be transferred between cells by extracellular vesicles.Eur J Immunol. 2018;48(10): 1621-1631
Braciak TA, Roskopf CC, Wildenhain S, Fenn NC, Schiller CB, Schubert IA, Jacob U, Honegger A, Krupka C, Subklewe M, Spiekermann K, Hopfner KP, Fey GH, Aigner M, Krause S, Mackensen A, Oduncu FS:(2018)Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells.Oncoimmunology. 2018;7(9):
Mangolini M, Götte F, Moore A, Ammon T, Oelsner M, Lutzny-Geier G, Klein-Hitpass L, Williamson JC, Lehner PJ, Dürig J, Möllmann M, Rásó-Barnett L, Hughes K, Santoro A, Méndez-Ferrer S, Oostendorp RAJ, Zimber-Strobl U, Peschel C, Hodson DJ, Schmidt-Supprian M, Ringshausen I:(2018)Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia.Nat Commun. 2018;9(1):
Achita P, Dervovic D, Ly D, Lee JB, Haug T, Joe B, Hirano N, Zhang L:(2018)Infusion of ex-vivo expanded human TCR-αβ+ double-negative regulatory T cells delays onset of xenogeneic graft-versus-host disease.Clin Exp Immunol. 2018;193(3): 386-399
Pfeiffer H, Völkl S, Gary R, Mackensen A, Achenbach S, Strasser E, Aigner M:(2018)Impact of collection programs for the generation of monocyte apheresis products on product quality and composition as starting material for the generation of cellular therapeutics.Transfusion. 2018;58(9): 2175-2183
Gocht A, Spriewald B, Distler JHW, Ramsperger-Gleixner M, Ensminger SM, Weyand M, Heim C:(2018)Small Molecule Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Cardiac Allograft Vasculopathy in Murine Aortic Allografts.Transplant Direct. 2018;4(7):
Tognarelli S, Wirsching S, von Metzler I, Rais B, Jacobs B, Serve H, Bader P, Ullrich E:(2018)Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma.Front Immunol. 2018;9():
Jitschin R, Saul D, Braun M, Tohumeken S, Völkl S, Kischel R, Lutteropp M, Dos Santos C, Mackensen A, Mougiakakos D:(2018)CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells.J Immunother Cancer. 2018;6(1):
Iacobaeus E, Douagi I, Jitschin R, Marcusson-Ståhl M, Andrén AT, Gavin C, Lefsihane K, Davies LC, Mougiakakos D, Kadri N, Le Blanc K:(2018)Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosis.Immunol Cell Biol. 2018;96(8): 820-830
Frick M, Chan W, Arends CM, Hablesreiter R, Halik A, Blau O, Heuser M, Michonneau D, Galan-Sousa J, Noerenberg D, Wais V, Stadler M, Yoshida K, Schetelig J, Schuler E, Thol F, Clappier E, Christopeit M, Ayuk FA, Bornhaeuser M, Blau IW, Ogawa S, Zemojtel T, Gerbitz A, Spriewald BM, Schrezenmeier H, Kuchenbauer F, Kobbe G, Wiesneth M, Koldehoff M, Socie G, Kroeger N, Bullinger L, Thiede C, Damm F:(2018)The role of donor clonal hematopoiesis in allogeneic hematopoietic stem cell transplantationOncology Research and Treatment. 2018;41(): 13-13
Preiss A, Bach C, Arnold M, Spriewald B, Banas B, Zecher D:(2018)PREVALENCE AND IMPACT OF PREFORMED ANTI-HLA ANTIBODIES OF THE IGA ISOTYPE IN KIDNEY TRANSPLANTATIONTranspl Int. 2018;31(): 24-25
Arnold ML, Bach C, Spriewald BM:(2018)IGA ISOTYPE ANTI-HLA ANTIBODIES AND ORGAN GRAFT SURVIVAL IN KIDNEY TRANSPLANTATIONTranspl Int. 2018;31(): 28-28
Gemeinhardt A, McDonald MP, König K, Aigner M, Mackensen A, Sandoghdar V:(2018)Label-Free Imaging of Single Proteins Secreted from Living Cells via iSCAT Microscopy.J Vis Exp. 2018;(141):
Ugele M, Weniger M, Stanzel M, Bassler M, Krause SW, Friedrich O, Hayden O, Richter L:(2018)Label-Free High-Throughput Leukemia Detection by Holographic Microscopy.Adv Sci (Weinh). 2018;5(12):
Thurner L, Preuss KD, Bewarder M, Kemele M, Fadle N, Regitz E, Altmeyer S, Schormann C, Poeschel V, Ziepert M, Walter S, Roth P, Weller M, Szczepanowski M, Klapper W, Monoranu C, Rosenwald A, Möller P, Hartmann S, Hansmann ML, Mackensen A, Schäfer H, Schorb E, Illerhaus G, Buslei R, Bohle RM, Stilgenbauer S, Kim YJ, Pfreundschuh M:(2018)Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma.Blood. 2018;132(26): 2744-2753
Wuerfel F, Erber R, Huebner H, Hein A, Lux MP, Jud S, Kremer A, Kranich H, Mackensen A, Haeberle L, Hack CC, Rauh C, Wunderle M, Gass P, Rabizadeh S, Brandl AL, Langemann H, Volz B, Nabieva N, Schulz-Wendtland R, Dudziak D, Beckmann MW, Hartmann A, Fasching PA, Ruebner M:(2018)TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating LymphocytesBreast Care (Basel). 2018;13(1): 8-14
Erber R, Hartmann A, Beckmann MW, Mackensen A, Kremer A, Reimann H, Hübner H, Hein A, Lux MP, Jud S, Häberle L, Gaß P, Volz B, Schulz-Wendtland R, Rübner M, Fasching PA:(2018)[TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes].Pathologe. 2018;39(Suppl 2): 236-240
Wehrstedt S, Kubis J, Zimmermann A, Bruns H, Mayer D, Grieshober M, Stenger S:(2018)The tyrosine kinase inhibitor dasatinib reduces the growth of intracellular Mycobacterium tuberculosis despite impairing T-cell function.Eur J Immunol. 2018;48(11): 1892-1903
Lee JH, Ostalecki C, Zhao Z, Kesti T, Bruns H, Simon B, Harrer T, Saksela K, Baur AS:(2018)HIV Activates the Tyrosine Kinase Hck to Secrete ADAM Protease-Containing Extracellular Vesicles.EBioMedicine. 2018;28(): 151-161
Urbanczyk S, Stein M, Schuh W, Jäck HM, Mougiakakos D, Mielenz D:(2018)Regulation of Energy Metabolism during Early B Lymphocyte Development.Int J Mol Sci. 2018;19(8):
Saussele S, Hehlmann R, Fabarius A, Jeromin S, Proetel U, Rinaldetti S, Kohlbrenner K, Einsele H, Falge C, Kanz L, Neubauer A, Kneba M, Stegelmann F, Pfreundschuh M, Waller CF, Oppliger Leibundgut E, Heim D, Krause SW, Hofmann WK, Hasford J, Pfirrmann M, Müller MC, Hochhaus A, Lauseker M:(2018)Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV.Leukemia. 2018;32(5): 1222-1228
Gocht A, Distler JHW, Spriewald B, Ramsperger-Gleixner M, Weyand M, Ensminger SM, Heim C:(2018)Effects of different serotonin receptor subtype antagonists on the development of cardiac allograft vasculopathy in murine aortic allografts.Transpl Immunol. 2018;49(): 43-53
Schink K, Relijic D, Herrmann HJ, Meyer J, Mackensen A, Neurath MF, Zopf Y:(2018)Whole-Body Electromyostimulation Combined With Individualized Nutritional Support Improves Body Composition in Patients With Hematological Malignancies - A Pilot StudyFront Physiol. 2018;9():

Publikationen 2018

Publikationen 2018

Notfall

Notfallinformationen UKER

Patienten & Besucher

Ärzte & Zuweiser

Forschung

Lehre